Skip to content
10-Q

Quarterly Report

Whitehawk Therapeutics, Inc. WHWK

0001193125-26-212075

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 49.45M sh
Shares Diluted Q1 2026 · Mar 31, 2026 69.24M sh
Shares Diluted Q1 2026 · Mar 31, 2025 39.93M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $551K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$22.21M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$11.86M
Short Term Investments Q1 2026 · Mar 31, 2026 $88.25M
Short Term Investments Q1 2026 · Dec 31, 2025 $108.13M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $34.79M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $37.57M
Stockholders Equity Q1 2026 · Mar 31, 2026 $116.18M
Stockholders Equity Q1 2026 · Dec 31, 2025 $136.31M
Stockholders Equity Q1 2026 · Mar 31, 2025 $221.73M
Stockholders Equity Q1 2026 · Dec 31, 2024 $52.48M
Current Liabilities Q1 2026 · Mar 31, 2026 $11.06M
Current Liabilities Q1 2026 · Dec 31, 2025 $14.52M
Total Liabilities Q1 2026 · Mar 31, 2026 $11.06M
Total Liabilities Q1 2026 · Dec 31, 2025 $14.52M
Current Assets Q1 2026 · Mar 31, 2026 $125.55M
Current Assets Q1 2026 · Dec 31, 2025 $149.01M
Total Assets Q1 2026 · Mar 31, 2026 $127.23M
Total Assets Q1 2026 · Dec 31, 2025 $150.83M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.32
Eps Diluted Q1 2026 · Mar 31, 2025 $1.83
Eps Basic Q1 2026 · Mar 31, 2026 −$0.32
Eps Basic Q1 2026 · Mar 31, 2025 $1.84
Sga Expense Q1 2026 · Mar 31, 2026 $6.29M
Sga Expense Q1 2026 · Mar 31, 2025 $12.82M
Rd Expense Q1 2026 · Mar 31, 2026 $17.23M
Rd Expense Q1 2026 · Mar 31, 2025 $8.79M
Net Income Q1 2026 · Mar 31, 2026 −$22.19M
Net Income Q1 2026 · Mar 31, 2025 $73.02M
Operating Income Q1 2026 · Mar 31, 2026 −$23.52M
Operating Income Q1 2026 · Mar 31, 2025 −$15.22M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $0
Cost Of Revenue Q1 2026 · Mar 31, 2025 $760K
Revenue Q1 2026 · Mar 31, 2026 $0
Revenue Q1 2026 · Mar 31, 2025 $7.15M